Odense University Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2024

  1. Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial

    Gynecologic Oncology, Vol. 187, pp. 128-138

2023

  1. Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain

    Pain Management, Vol. 13, Núm. 2, pp. 115-127

2018

  1. Risk factors for unfavourable postoperative outcome in patients with Crohn's disease undergoing right hemicolectomy or ileocaecal resection. An international audit by ESCP and S-ECCO

    Colorectal Disease, Vol. 20, Núm. 3, pp. 219-227

2017

  1. Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

    Obstetrical and Gynecological Survey

2016

  1. Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer

    New England Journal of Medicine, Vol. 375, Núm. 22, pp. 2154-2164

2015

  1. Melanoma early detection and awareness: How countries developing melanoma awareness programs could benefit from melanoma-proficient countries

    American Journal of Therapeutics

2012

  1. Mortality after surgery in Europe: A 7 day cohort study

    The Lancet, Vol. 380, Núm. 9847, pp. 1059-1065